The confirmation of this experimental study will provide a complementary treatment for prostate cancer in addition to potential therapy, anti-AR therapy, chemotherapy, and other conventional treatment methods, and provide some research ideas and basis for the mechanism of the drug. This evidence concerns the gene AR and Familial prostate cancer.